DNA repair defects in stem cell function and aging

Annual Review of Medicine

Volumn 56, Issue , 2005, Pages 495-508

  Park, Youngji ^a   Gerson, Stanton L ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Aplastic anemia; DNA repair pathways; Hematopoietic stem cells (HSC) transplantation

Indexed keywords

6 O ALKYLGUANINE DNA ALKYLTRANSFERASE; BRCA1 PROTEIN; BRCA2 PROTEIN; CD34 ANTIGEN; CELL DNA; CYCLIN DEPENDENT KINASE INHIBITOR; FANCONI ANEMIA PROTEIN; PROTEIN; PROTEIN MSH2; PROTEIN P53; TELOMERASE; UNCLASSIFIED DRUG;

AGING; APOPTOSIS; CELL CYCLE; CELL DIFFERENTIATION; CELL FUNCTION; DNA DAMAGE; DNA RECOMBINATION; DNA REPAIR; EMBRYONIC STEM CELL; EXCISION REPAIR; FANCONI ANEMIA; GENE EXPRESSION; GENOMIC INSTABILITY; GENOTOXICITY; HEMATOPOIETIC STEM CELL; HUMAN; LONGEVITY; MALIGNANT TRANSFORMATION; MISMATCH REPAIR; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRESS;

AGING, PREMATURE; ANIMALS; CELL AGING; CELL TRANSFORMATION, NEOPLASTIC; DNA DAMAGE; DNA MUTATIONAL ANALYSIS; DNA REPAIR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA;

EID: 14544268189     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.56.082103.104546     Document Type: Review

References (75)

1. Schlessinger D, Van Zant G. 2001. Does functional depletion of stem cells drive aging? Mech. Ageing Dev. 122:1537
2. Rao M, Mattson M. 2001. Stem cells and aging: expanding the possibilities. Mech. Ageing Dev. 122:713
3. de Boer J, Andressoo J, de Wit J, et al. 2002. Premature aging in mice deficient in DNA repair and transcription. Science 296:1276-79
4. Walter C, Zhou Z, Manguino D, et al. 2001. Health span and life span in transgenic mice with modulated DNA repair. Ann. NY Acad. Sci. 928:132
5. Harrison D, Astle C, Stone M. 1989. Number and functions of transplantable primitive immunohematopoietic stem cells. Effects of age. J. Immunol. 142:3833
6. Essers J, van Steeg H, de Wit J, et al. 2000. Homologous and non-homologous recombination differentially affect DNA damage repair in mice. EMBO J. 19:1703-10
7. Gerson SL. 2004. MGMT: its role in cancer aetiology and cancer therapeutics. Nat. Rev. Cancer 4:296-307
8. Shiraishi A, Sakumi K, Sekiguchi M. 2000. Increased susceptibility to chemotherapeutic alkylating agents of mice deficient in DNA repair methyltransferase. Carcinogenesis 21:1879-83
9. 6-alkylguanine-DNA alkyltransferase. Science 259:219-22
10. Reese JS, Qin X, Ballas CB, et al. 2001. MGMT expression in murine bone marrow is a major determinant of animal survival after alkylating agent exposure. J. Hematother. Stem Cell Res. 10:115-23
11. Friedberg EC. 2001. How nucleotide excision repair protects against cancer. Nat. Rev. Cancer 1:22-33
12. Tsutakawa SE, Cooper PK. 2000. Transcription-coupled repair of oxidative DNA damage in human cells: mechanisms and consequences. Cold Spring Harbor Symp. Quant. Biol. 65:201-15
13. Lindahl T, Wood RD. 1999. Quality control by DNA repair. Science 286:1897-905
14. Klungland A, Lindahl T. 1997. Second pathway for completion of human DNA base excision-repair: reconstitution with purified proteins and requirement for DNase IV (FEN1). EMBO J. 16:3341-48
15. Ṡchmutte C, Sadoff MM, Shim KS, et al. 2001. The interaction of DNA mismatch repair proteins with human exonuclease I. J. Biol. Chem. 276:33011-18
16. Peltomaki P, Vasen HF. 1997. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology 113:1146-58
17. Wei K, Kucherlapati R, Edelmann W. 2002. Mouse models for human DNA mismatch-repair gene defects. Trends Mol. Med. 8: 346-53
18. Lieber MR, Ma Y, Pannicke U, Schwarz K. 2003. Mechanism and regulation of human non-homologous DNA end-joining. Nat. Rev. Mol. Cell Biol. 4:712-20
19. DeFazio LG, Stansel RM, Griffith JD, et al. 2002. Synapsis of DNA ends by DNA-dependent protein kinase. EMBO J. 21:3192-200
20. Ramsden DA, Gellert M. 1998. Ku protein stimulates DNA end joining by mammalian DNA ligases: a direct role for Ku in repair of DNA double-strand breaks. EMBO J. 17:609-14
21. Ma Y, Pannicke U, Schwarz K, et al. 2002. Hairpin opening and overhang processing by an Artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell 108:781-94
22. Nick McElhinny SA, Snowden CM, McCarville J, et al. 2000. Ku recruits the XRCC4-ligase IV complex to DNA ends. Mol. Cell Biol. 20:2996-3003
23. Moshous D, Callebaut I, de Chasseval R, et al. 2001. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 105:177-86
24. Valerie K, Povirk LF. 2003. Regulation and mechanisms of mammalian double-strand break repair. Oncogene 22:5792-812
25. Bakkenist CJ, Kastan MB. 2003. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421:499-506
26. Ramalho-Santos M, Yoon A, Matsuzaki Y, et al. 2002. "Stemness": transcriptional profiling of embryonic and adult stem cells. Science 298:597
27. Ivanova N, Dimos J, Schaniel C, et al. 2002. A stem cell molecular signature. Science 298:601
28. Cervantes RB, Stringer JR, Shao C, et al. 2002. Embryonic stem cells and somatic cells differ in mutation frequency and type. Proc. Natl. Acad. Sci. USA 99:3586-90
29. Van Sloun PP, Jansen JG, Weeda G, et al. 1999. The role of nucleotide excision repair in protecting embryonic stem cells from genotoxic effects of UV-induced DNA damage. Nucleic Acids Res. 27:3276-82
30. - bone marrow cells. Mutat. Res. 425:169-76
31. + progenitor cells corresponds to increased drug sensitivity and apoptotic response. Blood 100:845-53
32. D'Andrea AD, Grompe M. 2003. The Fanconi anaemia/BRCA pathway. Nat. Rev. Cancer 3:23-34
33. Taniguchi T, Garcia-Higuera I, Andreassen PR, et al. 2002. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 100:2414-20
34. Garcia-Higuera I, Taniguchi T, Ganesan S, et al. 2001. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 7:249-62
35. Chen M, Tomkins DJ, Auerbach W, et al. 1996. Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia. Nat. Genet. 12:448-51
36. + primitive hematopoietic cells and shows reduced reconstruction ability. Exp. Hematol. 27:166774
37. Venkitaraman AR. 2002. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108:171-82
38. Howlett NG, Taniguchi T, Olson S, et al. 2002. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297:606-9
39. Reese J, Liu L, Gerson S. 2003. Repopulating defects of mismatch repair-deficient hematopoietic stem cells. Blood 102:1626-33
40. Harley CB, Futcher AB, Greider CW. 1990. Telomeres shorten during ageing of human fibroblasts. Nature 345:458-60
41. Allsopp RC, Morin GB, DePinho R, et al. 2003. Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation. Blood 102:517-20
42. de Lange T. 2002. Protection of mammalian telomeres. Oncogene 21:532-40
43. -/- mice and patients with ataxia-telangiectasia. Hum. Mol. Genet. 10:519-28
44. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, et al. 2003. A DNA damage scheckpoint response in telomere-initiated senescence. Nature 426:194-98
45. Vulliamy T, Marrone A, Dokal I, Mason PJ. 2002. Association between aplastic anaemia and mutations in telomerase RNA. Lancet 359:2168-70
46. Yamaguchi H, Baerlocher GM, Lansdorp PM, et al. 2003. Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome. Blood 102:916-18
47. Vulliamy T, Marrone A, Szydlo R, et al. 2004. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat. Genet. 36:441-49
48. Vulliamy T, Marrone A, Goldman F, et al. 2001. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 413:432-35
49. Blasco MA, Lee HW, Hande MP, et al. 1997. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91:25-34
50. Mason PJ. 2003. Stem cells, telomerase and dyskeratosis congenita. Bioessays 25:126-33
51. Ruggero D, Grisendi S, Piazza F, et al. 2003. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science 299:259-62
52. Yuan Y, Shen H, Franklin DS, et al. 2004. In vivo self-renewing divisions of haematopoietic stem cells are increased in the absence of the early G1-phase inhibitor, p18INK4C. Nat. Cell Biol. 6:436-42
53. Cheng T, Rodrigues N, Shen H, et al. 2000. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 287:1804-8
54. Cheng T, Rodrigues N, Dombkowski D, et al. 2000. Stem cell repopulation efficiency but not pool size is governed by p27(kip1). Nat. Med. 6:1235-40
55. Mohaghegh P, Hickson I. 2002. Premature aging in RecQ helicase-deficient human syndromes. Int. J. Biochem. Cell. Biol 34:1496
56. Lombard DB, Beard C, Johnson B, et al. 2000. Mutations in the WRN gene in mice accelerate mortality in a p53-null background. Mol. Cell Biol. 20:3286-91
57. Kyng KJ, May A, Kolvraa S, et al. 2003. Gene expression profiling in Werner syndrome closely resembles that of normal aging. Proc. Natl. Acad. Sci. USA 100:12259-64
58. Karmakar P, Snowden CM, Ramsden DA, et al. 2002. Ku heterodimer binds to both ends of the Werner protein and functional interaction occurs at the Werner N-terminus. Nucleic Acids Res. 30:3583-91
59. Li B, Comai L. 2000. Functional interaction between Ku and the Werner syndrome protein in DNA end processing. J. Biol. Chem. 275:28349-52
60. Adelfalk C, Kontou M, Hirsch-Kauffmann M, et al. 2003. Physical and functional interaction of the Werner syndrome protein with poly-ADP ribosyl transferase. FEBS Lett. 554:55-58
61. von Kobbe C, Harrigan JA, May A, et al. 2003. Central role for the Werner syndrome protein/poly(ADP-ribose) polymerase 1 complex in the poly(ADP-ribosyl)ation pathway after DNA damage. Mol. Cell Biol. 23:8601-13
62. Lebel M, Leder P. 1998. A deletion within the murine Werner syndrome helicase induces sensitivity to inhibitors of topoisomerase and loss of cellular proliferative capacity. Proc. Natl. Acad. Sci. USA 95:13097-102
63. Lebel M, Spillare EA, Harris CC, et al. 1999. The Werner syndrome gene product co-purifies with the DNA replication complex and interacts with PCNA and topoisomerase I. J. Biol. Chem. 274:37795-99
64. Grigorova M, Balajee AS, Natarajan AT. 2000. Spontaneous and X-ray-induced chromosomal aberrations in Werner syndrome cells detected by FISH using chromosome-specific painting probes. Mutagenesis 15:303-10
65. Yannone SM, Roy S, Chan DW, et al. 2001. Werner syndrome protein is regulated and phosphorylated by DNA-dependent protein kinase. J. Biol. Chem. 276:38242-48
66. Chester N, Kuo F, Kozak C, et al. 1998. Stage-specific apoptosis, developmental delay, and embryonic lethality in mice homozygous for a targeted disruption in the murine Bloom's syndrome gene. Genes Dev. 12:3382-93
67. Luo G, Santoro IM, McDaniel LD, et al. 2000. Cancer predisposition caused by elevated mitotic recombination in Bloom mice. Nat. Genet. 26:424-29
68. Vogel H, Lim DS, Karsenty G, et al. 1999. Deletion of Ku86 causes early onset of senescence in mice. Proc. Natl. Acad. Sci. USA 96:10770-75
69. Pandita TK. 2001. The role of ATM in telomere structure and function. Radiation Res. 156:642-47
70. Elson A, Wang Y, Daugherty CJ, et al. 1996. Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proc. Natl. Acad. Sci. USA 93:13084-89
71. Wong K, Maser R, Bachoo R, et al. 2003. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates aging. Nature 421:643
72. Hasty P, Campisi J, Hoeijmakers J, et al. 2003. Aging and genome maintenance. Science 299:1355-58
73. Weeda G, Donker I, de Wit J, et al. 1997. Disruption of mouse ERCC1 results in a novel repair syndrome with growth failure, nuclear abnormalities and senescence. Curr. Biol. 7:427-39
74. Zhu XD, Niedernhofer L, Kuster B, et al. 2003. ERCC1/XPF removes the 3′ overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes. Mol. Cell. 12:1489-98
75. Trifunovic A, Wredenberg A, Falkenberg M, et al. 2004. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429:417-23